Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06298214
Other study ID # RP-23-019
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date April 1, 2024
Est. completion date June 1, 2026

Study information

Verified date February 2024
Source Woman's
Contact Briasha Jones, MPH
Phone 225-428-7464
Email briasha.jones@womans.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this clinical trial is to learn if a program Woman's Hospital has made, called the Her Health Program, can help women be healthy and get healthcare in the first year after having a baby. The main question[s] the study aims to answer are: - Can the Her Health program increase access to healthcare in the first year postpartum? - Can the Her Health program increase knowledge about healthcare and change feelings toward the healthcare system? Participants will complete one research visit in which they will be enrolled and told which group they will be in- "Her Health Program" group or "Usual Care" group. If they are placed in the "Her Health Program" group, they will receive their usual care + the addition of an extra healthcare team member(called a community health navigator) to to work with patients and care team for a year postpartum. Researchers will compare those who receive the Her Health Program and those who do not receive the program to see if the Her Health Program can help women get healthcare in the first year after having a baby.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 500
Est. completion date June 1, 2026
Est. primary completion date January 1, 2026
Accepts healthy volunteers No
Gender Female
Age group 16 Years and older
Eligibility Inclusion Criteria: - At least 16 years old at the time of consent. - Gave birth within 7 days before randomization - Medicaid enrolled - Address of residence within a disadvantaged area (ADI>5). - Clearly understands the study procedures and visit schedule, alternative treatments, and risks involved with the study, and voluntarily agrees to participate by giving verbal and written informed consent Exclusion Criteria: - Use of private health insurance exclusively - Does not speak English. - Plans to move out of state during the study time period - Unwilling to provide permission to link study records, medical records, and Medicaid and Vital Records Database records. - Unwilling to provide informed consent - Unwilling to be randomized.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Her Health Program
Addition of a community health worker navigator to assist subject in navigating their health in the first year postpartum.

Locations

Country Name City State
United States Woman's Hospital Baton Rouge Louisiana

Sponsors (2)

Lead Sponsor Collaborator
Elizabeth F Sutton, PhD Donaghue Medical Research Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Postpartum visit attendance Visit attended between 6-12 weeks of delivery (yes/no) 12 weeks postpartum
Secondary Medical trust Group-Based Medical Mistrust Scale; scores range from 12-60 with higher scores indicating more mistrust 12 months postpartum
Secondary Health literacy Rapid Estimate of Adult Literacy in Medicine (REALM); scores 0-66; higher score indicates high literacy 12 months postpartum
Secondary Self-efficacy PROMIS General Self-Efficacy; scores range 5-50; higher score indicates higher self-efficacy 12 months postpartum
Secondary Healthcare costs total cost of healthcare from Medicaid Claims Database within the first 12 months after delivery 12 months postpartum
See also
  Status Clinical Trial Phase
Completed NCT05017974 - Research on Improving Sleep During Pregnancy N/A
Completed NCT03284515 - Vaccination In Pregnancy Gene Signature: VIP Signature Study
Recruiting NCT05969795 - Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support Phase 1
Recruiting NCT06051201 - Innovation for Small-scale Experiments: ReceptIVFity Test N/A
Recruiting NCT04828382 - Prospective Study of Pregnancy in Women With Cystic Fibrosis
Enrolling by invitation NCT04527926 - STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy N/A
Recruiting NCT04278651 - Early Antenatal Support for Iron Deficiency Anemia Phase 4
Recruiting NCT04405700 - Measuring Adverse Pregnancy and Newborn Congenital Outcomes
Recruiting NCT06258902 - Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
Completed NCT05487196 - Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia Phase 2
Completed NCT03750968 - Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects Phase 2
Enrolling by invitation NCT06127277 - Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care N/A
Completed NCT05897697 - Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
Recruiting NCT05899101 - The Impact of Opioid and Cannabis Exposure on Fetal Growth
Completed NCT05502510 - Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
Completed NCT04296396 - Opioid Prescription After Cesarean Trial Phase 3
Not yet recruiting NCT06069869 - Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06069856 - Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial Phase 3
Not yet recruiting NCT06163651 - Evaluating a One-Year Version of the Parent-Child Assistance Program N/A
Not yet recruiting NCT06079918 - Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania Phase 3